Loss of normal huntingtin function: new developments in Huntington's disease research

被引:290
作者
Cattaneo, E
Rigamonti, D
Goffredo, D
Zuccato, C
Squitieri, F
Sipione, S
机构
[1] Univ Milan, Inst Pharmacol Sci, I-20133 Milan, Italy
[2] IRCCS, Neurogenet Unit, Pozzilli, Isernia, Italy
关键词
D O I
10.1016/S0166-2236(00)01721-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease is characterized by a loss of brain striatal neurons that occurs as a consequence of an expansion of a CAG repeat in the huntingtin protein. The resulting extended polyglutamine stretch confers a deleterious gain-of-function to the protein. Analysis of the mutant protein has attracted most of the research activity in the field, however re-examination of earlier data and new results on the beneficial functions of normal huntingtin indicate that loss of the normal protein function might actually equally contribute to the pathology. Thus, complete elucidation of the physiological role(s) of huntingtin and its mode of action are essential and could lead to new therapeutic approaches.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 86 条
  • [1] HEAT REPEATS IN THE HUNTINGTONS-DISEASE PROTEIN
    ANDRADE, MA
    BORK, P
    [J]. NATURE GENETICS, 1995, 11 (02) : 115 - 116
  • [2] Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin
    Bao, J
    Sharp, AH
    Wagster, MV
    Becher, M
    Schilling, G
    Ross, CA
    Dawson, VL
    Dawson, TM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) : 5037 - 5042
  • [3] MOUSE HUNTINGTONS-DISEASE GENE HOMOLOG (HDH)
    BARNES, GT
    DUYAO, MP
    AMBROSE, CM
    MCNEIL, S
    PERSICHETTI, F
    SRINIDHI, J
    GUSELLA, JF
    MACDONALD, ME
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1994, 20 (02) : 87 - 97
  • [4] Energetics in the pathogenesis of neurodegenerative diseases
    Beal, MF
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (07) : 298 - 304
  • [5] Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
    Becher, MW
    Kotzuk, JA
    Sharp, AH
    Davies, SW
    Bates, GP
    Price, DL
    Ross, CA
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 4 (06) : 387 - 397
  • [6] Fast transport and retrograde movement of huntingtin and HAP 1 in axons
    BlockGalarza, J
    Chase, KO
    Sapp, E
    Vaughn, KT
    Vallee, RB
    DiFiglia, M
    Aronin, N
    [J]. NEUROREPORT, 1997, 8 (9-10) : 2247 - 2251
  • [7] Huntingtin interacts with cystathionine β-synthase
    Boutell, JM
    Wood, JD
    Harper, PS
    Jones, AL
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (03) : 371 - 378
  • [8] Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin
    Boutell, JM
    Thomas, P
    Neal, JW
    Weston, VJ
    Duce, J
    Harper, PS
    Jones, AL
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (09) : 1647 - 1655
  • [9] Brinkman RR, 1997, AM J HUM GENET, V60, P1202
  • [10] Huntington and DRPLA proteins selectively interact with the enzyme GAPDH
    Burke, JR
    Enghild, JJ
    Martin, ME
    Jou, YS
    Myers, RM
    Roses, AD
    Vance, JM
    Strittmatter, WJ
    [J]. NATURE MEDICINE, 1996, 2 (03) : 347 - 350